Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
MSFT -7.61META 3.94BKNG 1.55HMP.TO 0SPGP 0.13ZUQ.TO -0.39NVDA -3.18GL 1.93
Valeant Pharmaceuticals (VRX.TO)

Valeant Pharmaceuticals (VRX.TO)

0.00
-0.00 (0.00%)
39 watching
Icon Financials Financials Icon Analysis Technical Analysis
Interactive Chart
1w 1m 6m 1y
0
PAST TOP PICK

Valeant Pharmaceuticals(VRX.TO)

Dec 05, 2002
(Was a top pick on Sept 19. Up 36%) Still likes.
Photo of John ZechnerJohn ZechnerUnlock Rating
$52.33

Stock price when the opinion was issued

Healthcare
DON'T BUY

Valeant Pharmaceuticals(VRX.TO)

Dec 03, 2002
Likes the company, but a little pricey right now.
Photo of David DriscollDavid DriscollUnlock Rating
$53.50

Stock price when the opinion was issued

Healthcare
DON'T BUY

Valeant Pharmaceuticals(VRX.TO)

Nov 06, 2002
Very volatile. Looks cheap, but some accounting issues. Speculative.
Photo of Laura WallaceLaura WallaceUnlock Rating
$50.84

Stock price when the opinion was issued

Healthcare
DON'T BUY

Valeant Pharmaceuticals(VRX.TO)

Oct 31, 2002
Good company, but too expensive. Terrific products.
Photo of David BaskinDavid BaskinUnlock Rating
$49.31

Stock price when the opinion was issued

Healthcare
TOP PICK

Valeant Pharmaceuticals(VRX.TO)

Oct 30, 2002
(Was a top pick on Jan 7. Down 44.7%.) Still likes. Volatile because of new drugs and FDA approvals.
Photo of Gordon Higgins, CA, MBAGordon Higgins, CA, MBAUnlock Rating
$49.56

Stock price when the opinion was issued

Healthcare
TOP PICK

Valeant Pharmaceuticals(VRX.TO)

Oct 28, 2002
Should grow at 30% over the next couple of years. Health care environment will continue to be positive.
Photo of David BurrowsDavid BurrowsUnlock Rating
$49.50

Stock price when the opinion was issued

Healthcare
BUY

Valeant Pharmaceuticals(VRX.TO)

Oct 18, 2002
Profitable. Good contracts. Has decent longer term prospects.
Photo of Gavin GrahamGavin GrahamUnlock Rating
$47.20

Stock price when the opinion was issued

Healthcare
TOP PICK

Valeant Pharmaceuticals(VRX.TO)

Oct 17, 2002
Performs well. Biotechs are starting to recover.
Photo of Nereo PiticcoNereo PiticcoUnlock Rating
$44.92

Stock price when the opinion was issued

Healthcare
TOP PICK

Valeant Pharmaceuticals(VRX.TO)

Oct 02, 2002
Should have double digit growth over the next few years. Trading at 12 X earnings.
Photo of John Sinkins, CFAJohn Sinkins, CFAUnlock Rating
$42.05

Stock price when the opinion was issued

Healthcare
WAIT

Valeant Pharmaceuticals(VRX.TO)

Oct 01, 2002
New drug coming out and if its successful, the stock will do well.
Photo of Joe ConnollyJoe ConnollyUnlock Rating
$41.30

Stock price when the opinion was issued

Healthcare
BUY

Valeant Pharmaceuticals(VRX.TO)

Sep 24, 2002
Delivering pretty strong earnings, but biotechs are all down.
Photo of Nereo PiticcoNereo PiticcoUnlock Rating
$36.69

Stock price when the opinion was issued

Healthcare
WAIT

Valeant Pharmaceuticals(VRX.TO)

Sep 20, 2002
Will drop furher. Good technology. On a 2/3 year basis, should do well.
Photo of Gavin GrahamGavin GrahamUnlock Rating
$38.51

Stock price when the opinion was issued

Healthcare
TOP PICK

Valeant Pharmaceuticals(VRX.TO)

Sep 19, 2002
13 X earnings, Good balance sheet.
Photo of John ZechnerJohn ZechnerUnlock Rating
$39.35

Stock price when the opinion was issued

Healthcare
BUY

Valeant Pharmaceuticals(VRX.TO)

Sep 13, 2002
Excellent earnings growth, but had some concerns. Has just bought.
Photo of Clos OlssonClos OlssonUnlock Rating
$42.51

Stock price when the opinion was issued

Healthcare
WEAK BUY

Valeant Pharmaceuticals(VRX.TO)

Sep 13, 2002
Aggressive company. Generates a lot of cash flow. Good price.
Photo of Jonathen Wellum, B. Comm, B. ScJonathen Wellum, B. Comm, B. ScUnlock Rating
$42.51

Stock price when the opinion was issued

Healthcare
Showing 586 to 600 of 714 entries

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

FCX 0.575$70.705
MU -49.615$1038.375
WDC 37.37$690.9
AAPL 2.3$298.72
SPCX 19.16$211.66
The ultimate 360° Tracker Your financial life in one place, automaticallywealthica-video

Today's Top Picks

MSFT -7.61$392.15
META 3.94$597.42
BKNG 1.55$176.19
HMP.TO 0$9.76
SPGP 0.13$121.73

Popular Articles

Latest Sell Signals

CRWD -12.785$680.125
MSFT -7.61$392.15
SCCO 1.725$194.945
ADBE 0.515$206.875
PEP -0.15$146.1

Most Recent Experts

Joe Terranova

Joe Terranova

Virtus Investment Partners

Stephen Weiss, Founder, Short Hills Capital Partners

Stephen Weiss, Founder, Short Hills Capital Partners

Short Hills Capital Partners

Rob Sechan, Managing Partner, New Edge Capital

Rob Sechan, Managing Partner, New Edge Capital

New Edge Capital

Gordon Reid

Gordon Reid

GoodReid Investment Counsel

Jim Cramer - Mad Money

Jim Cramer - Mad Money

CNBC

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica
The ultimate 360° Tracker Your financial life in one place, automaticallywealthica-video